Recombinant
RabMAb

Recombinant Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)

Submit a review Q&A (1)References (8)

Overview

  • Product name
    Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)]
    See all JAK1 primary antibodies
  • Description
    Rabbit monoclonal [EPR1899(2)] to JAK1 (phospho Y1022 + Y1023)
  • Host species
    Rabbit
  • Specificity
    According to our ELISA result, this antibody preferentially recognizes JAK1 with phospho Y1023, but also recognizes JAK1 with phospho Y1022 if high amount peptides were coated.
  • Tested applications
    Suitable for: WB, IHC-P, Dot blot, ELISAmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide within Human JAK1. The exact sequence is proprietary.

  • Positive control
    • Ramos cell lysates, treated with pervanadate; Human colon adenocarcinoma tissue, Human liver carcinoma.
  • General notes

    Mouse: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.

    We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.

    This product is a recombinant rabbit monoclonal antibody.

Properties

Applications

Our Abpromise guarantee covers the use of ab138005 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Predicted molecular weight: 133 kDa.
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

See IHC antigen retrieval protocols.
Dot blot Use at an assay dependent concentration.
ELISA Use at an assay dependent concentration.

Target

  • Function
    Tyrosine kinase of the non-receptor type, involved in the IFN-alpha/beta/gamma signal pathway. Kinase partner for the interleukin (IL)-2 receptor.
  • Tissue specificity
    Expressed at higher levels in primary colon tumors than in normal colon tissue. The expression level in metastatic colon tumors is comparable to the expression level in normal colon tissue.
  • Sequence similarities
    Belongs to the protein kinase superfamily. Tyr protein kinase family. JAK subfamily.
    Contains 1 FERM domain.
    Contains 1 protein kinase domain.
    Contains 1 SH2 domain.
  • Domain
    Possesses two phosphotransferase domains. The second one probably contains the catalytic domain (By similarity), while the presence of slight differences suggest a different role for domain 1.
    The FERM domain mediates interaction with JAKMIP1.
  • Cellular localization
    Endomembrane system. Wholly intracellular, possibly membrane associated.
  • Information by UniProt
  • Database links
    • Alternative names
      • JAK 1 antibody
      • JAK 1A antibody
      • JAK 1B antibody
      • JAK-1 antibody
      • JAK1 antibody
      • JAK1_HUMAN antibody
      • JAK1A antibody
      • JAK1B antibody
      • Janus kinase 1 (a protein tyrosine kinase) antibody
      • Janus kinase 1 antibody
      • JTK3 antibody
      • Tyrosine protein kinase JAK 1 antibody
      • Tyrosine protein kinase JAK1 antibody
      • Tyrosine-protein kinase JAK1 antibody
      see all

    Images

    • Western blot - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)
      Western blot - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)
      All lanes : Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005) at 1/5000 dilution

      Lane 1 : Untreated Ramos whole cell lysate
      Lane 2 : Ramos treated with 1mM pervandate for 30 minutes whole cell lysate

      Lysates/proteins at 10 µg per lane.

      Secondary
      All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution

      Predicted band size: 133 kDa
      Observed band size: 133 kDa



      Blocking and Diluting buffer 5% NFDM/TBST
    • Dot Blot - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)
      Dot Blot - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)

      Primary antibody: 1/1000 (unpurified)

      Secondary antibody: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051)

      Secondary ab dilution: 1/100,000

      Blocking buffer and concentration: 5% NFDM/TBST

      Diluting buffer and concentration: 5% NFDM /TBST

      Lane 1: JAK1 (pY1022) phospho peptide

      Lane 2: JAK1 (pY1023) phospho peptide

      Lane 3: JAK1 (pY1022/pY1023) phospho peptide

      Lane 4: JAK1 non-phospho peptide

      Exposure time: 3 minutes.

    • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)
      Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)

      Immunohistochemical analysis of paraffin-embedded human liver carcinoma sections labelling JAK1 (phospho Y1022 + Y1023) with purified ab138005 at dilution of 1/50. The secondary antibody used was ImmunoHistoProbe HRP Polymer for Rabbit IgG at dilution of 1:0. The sample was counterstained with hematoxylin. Antigen retrieval was performed using EDTA Buffer; pH 9.0. PBS was used instead of the primary antibody as the negative control and is shown in the inset.

    • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)
      Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)

      Immunohistochemical analysis of paraffin embedded Human colon adenocarcinoma tissue labelling JAK1 with unpurified ab138005 antibody at 1/50 dilution.

    • Western blot - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)
      Western blot - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)
      All lanes : Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005) at 1/1000 dilution (unpurified)

      Lane 1 : Ramos cell lysates
      Lane 2 : Ramos cell lysates, treated with pervanadate

      Lysates/proteins at 10 µg per lane.

      Secondary
      All lanes : goat anti-rabbit HRP at 1/2000 dilution

      Predicted band size: 133 kDa

    • ELISA - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)
      ELISA - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)

      Antigen:

      1. JAK1 (pY1022) phospho peptide
      2. JAK1 (pY1023) phospho peptide
      3. JAK1 non-phospho peptide

      Antigen concentration: 0~1000ng/ml

      Primary antibody concentration range: 1000ng/ml

      Secondary antibody: Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L), 1/2500 dilution

       

    • Other - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)
      Other - Anti-JAK1 (phospho Y1022 + Y1023) antibody [EPR1899(2)] (ab138005)
      Equilibrium disassociation constant (KD)
      Learn more about KD

      Click here to learn more about KD

    References

    This product has been referenced in:
    • Chen L  et al. Effects of purified Omphalia lapidescens protein on metastasis, cell cycle, apoptosis and the JAK-STAT signaling pathway in SGC-7901 human gastric cells. Oncol Lett 15:4161-4170 (2018). Read more (PubMed: 29541181) »
    • Zhao L  et al. Long non-coding RNA HULC promotes UVB-induced injury by up-regulation of BNIP3 in keratinocytes. Biomed Pharmacother 104:672-678 (2018). WB ; Human . Read more (PubMed: 29803927) »
    See all 8 Publications for this product

    Publishing research using ab138005? Please let us know so that we can cite the reference in this datasheet.

    Customer reviews and Q&As

    Show All Reviews Q&A
    Submit a review Submit a question

    Question

    Could I get the details of your pervanadate treatment in the WB image on the datasheet? The concentration, incubation time, and method of reconstituting would be very helpful.

    Read More
    Answer

    Thank you for contacting us. Please find below the notes on the image with pervanadate.


    Prepare 500mM stock Sodium Orthovanadate in PBS. To make
    100X Pervanadate right before experiment, add 400ul 500mM Sodium Orthovanadate to 1560ul H2O and then 40ul H2O2(Fisher #H325-100), vortex and incubate at RT for 5-10min.

    Cells are serum-starved for overnight, and then treated with freshly made Pervanadate for 20min at 37 degrees C.


    I hope this information is helpful to you. Please do not hesitate to contact us if you need any more advice or information.

    Read More

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
    For licensing inquiries, please contact partnerships@abcam.com

    Sign up